Medwell Capital Corp. is a Canadian-based service provider of capital and advisory services with a focus on investing in the healthcare industry, Learn more.
Medwell Capital is listed on the TSX Venture Exchange under the trading symbol "MWC"
Connect with current shareholder information, investing facts, stock price and more.
Mimetogen Pharmaceuticals Inc. Announces Initiation of a Phase 3 Clinical Trial with MIM-D3 to Treat Dry Eye Syndrome
To download the press release
please click here
Spectral Diagnostics' Phase III EUPHRATES trial in the newsPlease click the following link to view an ABC Action News feature on Spectral's Phase III EUPHRATES trial. The segment features EUPHRATES trial principal investigator Dr. Phillip Dellinger discussing the trial and potential patient outcomes. The segment also features a patient who shares her experience as a trial participant.
Clinical trial could help patients with sepsis
Wedbush analyst coverage of Spectral Diagnostics: